Hazim Rimawi, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2020 Meridian St Ste 110, Anderson, IN 46016 Phone: 765-683-3245 |
Tahir Ali Naqvi, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1340 N Madison Ave, Anderson, IN 46011 Phone: 765-298-1620 |
Brian L Eddy, MD Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1629 Medical Arts Blvd Ste 120, Anderson, IN 46011 Phone: 765-298-4220 Fax: 765-298-4942 |
News Archive
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the design, development and commercialization of first-in-class targeted oncolytic products for cancer, today presented preliminary data from a randomized dose-ranging Phase 2 trial of JX-594 in patients with advanced liver cancer showing a benefit in overall survival for the high dose group.
Initial 2012 reimbursement rates for Medicare Advantage plans should be roughly flat, which tops the consensus expectation of a 2 percent drop, according to Citi analyst Carl McDonald. McDonald said Tuesday in a research note the rates will be hurt by cuts from the health care overhaul, but he also thinks they will benefit from an adjustment to prior estimates.
Researchers at the University of Georgia are developing a new treatment technique that uses nanoparticles to reprogram immune cells so they are able to recognize and attack cancer. The findings were published recently in the early online edition of ACS Nano.
In a significant development for congenital heart disease patients, Medtronic, Inc. (NYSE: MDT), announced today that its Melody® Transcatheter Pulmonary Valve has received U.S. Food and Drug Administration (FDA) approval under a Humanitarian Device Exemption (HDE).
› Verified 8 days ago